Abstract
Oral Nanatinostat (Nstat) and Valganciclovir (VGCV) in Patients with Recurrent Epstein-Barr Virus (EBV)-Positive Lymphomas: Initial Phase 2 Results
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have